Depsides and depsidones
Medchemexpress LLC Phenyl benzoate | 93-99-2 | 99.9% | 198.22 | 10 G
Phenyl benzoate is a benzoate ester obtained by the formal condensation of phenol with benzoic acid. It acts as a chloride transport blocker, inhibiting Cl--dependent Glu accumulation into vesicles, and can also be used as a preservative in cosmetic products.
- Benzoate ester derived from phenol and benzoic acid
- Acts as a chloride transport blocker
- Inhibits Cl--dependent Glu accumulation
- Can be used as a preservative in cosmetic products
Medchemexpress LLC Alogliptin (Benzoate) | 850649-62-6 | 100.0% | C25H27N5O4 | 100 MG
Alogliptin Benzoate (SYR-322) is a potent, selective, and orally active inhibitor of DPP-4 with an IC50 of <10 nM. It exhibits greater than 10,000-fold selectivity over DPP-8 and DPP-9. It is used for the research of type 2 diabetes.
- Potent, selective, and orally active inhibitor of DPP-4
- IC50 of <10 nM
- Exhibits greater than 10,000-fold selectivity over DPP-8 and DPP-9
- Used for the research of type 2 diabetes
TARGETMOL CHEMICALS INC Physostigmine Salicylate 5MG
Also available in 1 mL, 1 mg, 2 mg, 10 mg, 25 mg, 50 mg, 100 mg, 500 mg and bulk. Please contact Fisher for quotes. Physostigmine, a parasympathomimetic alkaloid, is a reversible cholinesterase inhibitor. It extracts from the Calabar bean. Purity 99.36%
Medchemexpress LLC Alogliptin (benzoate) | 850649-62-6 | 99.98% | C25H27N5O4 | 500 MG
Alogliptin Benzoate (SYR-322) is a potent, selective, and orally active inhibitor of DPP-4 with an IC50 of <10 nM. It exhibits greater than 10,000-fold selectivity over DPP-8 and DPP-9 and can be used for the research of type 2 diabetes.
- Potent, selective, and orally active DPP-4 inhibitor
- High selectivity (greater than 10,000-fold) over DPP-8 and DPP-9
- Useful for research into type 2 diabetes
Medchemexpress LLC Alogliptin Benzoate (Standard) | 850649-62-6 | 99.3% | C25H27N5O4 | 5 MG
Alogliptin Benzoate (Standard) is an analytical standard of Alogliptin (Benzoate) for research and analytical applications. It is a potent, selective, and orally active inhibitor of DPP-4 with an IC50 of <10 nM, exhibiting over 10,000-fold selectivity over DPP-8 and DPP-9. This analytical standard is suitable for type 2 diabetes research and commonly employed in qualitative, quantitative, and methodological research experiments using techniques like HPLC, GC, and MS.
- Analytical standard for research and analytical applications
- Potent, selective, and orally active DPP-4 inhibitor
- IC50 of <10 nM
- Exhibits over 10,000-fold selectivity over DPP-8 and DPP-9
- Suitable for type 2 diabetes research
- Used in qualitative, quantitative, and methodological research experiments
- Compatible with HPLC, GC, and MS techniques
Medchemexpress LLC Alogliptin benzoate (standard) | 850649-62-6 | 99.31% | C25H27N5O4 | 50 MG
Alogliptin benzoate (Standard) is the analytical standard of Alogliptin benzoate, intended for research and analytical applications. It is a potent, selective, and orally active inhibitor of DPP-4 with an IC50 of <10 nM, exhibiting high selectivity over DPP-8 and DPP-9. This compound is suitable for the research of type 2 diabetes.
- Analytical standard for Alogliptin benzoate
- Potent, selective, and orally active inhibitor of DPP-4
- High selectivity over DPP-8 and DPP-9
- Used for research of type 2 diabetes
- Suitable for qualitative, quantitative, and methodological research experiments in HPLC, GC, and MS
Medchemexpress LLC Alogliptin Benzoate | 850649-62-6 | 100.0% | C25H27N5O4 | 50 MG
Alogliptin Benzoate (SYR-322) is a potent, selective, and orally active inhibitor of DPP-4 with an IC50 of <10 nM, exhibiting greater than 10,000-fold selectivity over DPP-8 and DPP-9. It is used for the research of type 2 diabetes.
- Potent and selective DPP-4 inhibitor
- Exhibits over 10,000-fold selectivity over DPP-8 and DPP-9
- Can be used for the research of type 2 diabetes
- Inhibits LPS-induced extracellular signal-regulated kinase (ERK) phosphorylation
- Reduces infarction area and improves brain vascular integrity in MCAO mice
Medchemexpress LLC Alogliptin (Benzoate) | 850649-62-6 | 99.7% | C25H27N5O4 | 25 MG
Alogliptin (Benzoate) is the analytical standard of Alogliptin (Benzoate), intended for research and analytical applications. It is a potent, selective, and orally active inhibitor of DPP-4 with an IC50 of <10 nM, exhibiting high selectivity over DPP-8 and DPP-9. This compound can be used for the research of type 2 diabetes and is suitable for qualitative, quantitative, and methodological research experiments in HPLC, GC, and MS.
- Used for research and analytical applications
- Potent, selective, and orally active inhibitor of DPP-4
- Exhibits high selectivity over DPP-8 and DPP-9
- Suitable for type 2 diabetes research
- Ideal for HPLC, GC, and MS research experiments
Medchemexpress LLC Alogliptin Benzoate (SYR 322) | 850649-62-6 | 100.0% | C25H27N5O4 | 200 MG
Alogliptin Benzoate (SYR-322) is a potent, selective, and orally active inhibitor of DPP-4 with an IC50 of <10 nM, exhibiting over 10,000-fold selectivity over DPP-8 and DPP-9. It is suitable for research into type 2 diabetes.
- Potent, selective, and orally active inhibitor of DPP-4.
- Inhibits LPS-induced extracellular signal-regulated kinase (ERK) phosphorylation in U937 cells.
- Inhibits LPS-stimulated MMP-1 secretion and mRNA expression mediated by the ERK pathway in U937 cells.
- Improves glucose tolerance and increases plasma insulin levels in female Wistar fatty rats.
- Reduces infarction area and improves brain vascular integrity in middle cerebral artery occlusion (MCAO) mice.
Medchemexpress LLC Fotagliptin benzoate | 1403496-40-1 | 99.2% | 464.49 g/mol | C24H25FN6O3 | 10MG
Fotagliptin benzoate is the benzoate salt form of fotagliptin, a potent dipeptidyl peptidase-4 (DPP-4) inhibitor used in preclinical research for Type 2 diabetes. The compound is supplied in small research quantities and is characterized for in vitro and in vivo formulations, with documented solubility and storage recommendations to support pharmacology studies.
- CAS 1403496-40-1.
- Molecular formula C24H25FN6O3 and molecular weight 464.49 g/mol.
- Reported DPP-4 inhibitory activity (IC50 ≈ 22.7 nM).
- High solubility in DMSO (100 mg/mL) and reported in vivo formulations with solubility ≥ 2.5 mg/mL.
- Storage: 4°C sealed; in solvent -80°C (6 months) or -20°C (1 month).
- Available in small pack sizes for research use (examples: 1 mg, 5 mg, 10 mg).